The ethics of creating genetically modified children using genome editing
- PMID: 28885275
- DOI: 10.1097/MED.0000000000000369
The ethics of creating genetically modified children using genome editing
Abstract
Purpose of review: To review the recent ethical, legal, and social issues surrounding human reproduction involving germline genome editing.
Recent findings: Genome editing techniques, such as CRISPR/Cas9, have facilitated genetic modification in human embryos. The most likely purpose of germline genome editing is the prevention of serious genetic disease in offspring. However, complex issues still remain, including irremediable risks to fetuses and future generations, the role of women, the availability of alternatives, long-term follow-up, health insurance coverage, misuse for human enhancement, and the potential effects on adoption. Further discussions, a broad consensus, and appropriate regulations are required before human germline genome editing is introduced into the global society.
Summary: Before germline genome editing is used for disease prevention, a broad consensus must be formed by carefully discussing its ethical, legal, and social issues.
Similar articles
-
Germline Editing: Editors Cautionary.Clin Ter. 2018 Mar-Apr;169(2):e58-e59. doi: 10.7417/T.2018.2053. Clin Ter. 2018. PMID: 29595865
-
The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.New Bioeth. 2019 Jun;25(2):137-152. doi: 10.1080/20502877.2019.1606151. New Bioeth. 2019. PMID: 31130112
-
Ethics of Human Genome Editing.Annu Rev Med. 2019 Jan 27;70:289-305. doi: 10.1146/annurev-med-112717-094629. Annu Rev Med. 2019. PMID: 30691366 Free PMC article. Review.
-
Safety of Germline Genome Editing for Genetically Related "Future" Children as Perceived by Parents.CRISPR J. 2019 Dec;2(6):370-375. doi: 10.1089/crispr.2019.0010. Epub 2019 Nov 19. CRISPR J. 2019. PMID: 31746634 Free PMC article.
-
Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.Development. 2017 Jan 1;144(1):3-7. doi: 10.1242/dev.139683. Development. 2017. PMID: 28049687 Review.
Cited by
-
Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.BMC Med Ethics. 2020 Sep 11;21(1):87. doi: 10.1186/s12910-020-00487-1. BMC Med Ethics. 2020. PMID: 32912206 Free PMC article.
-
Ethics assessment in research proposals adopting CRISPR technology.Biochem Med (Zagreb). 2019 Jun 15;29(2):020202. doi: 10.11613/BM.2019.020202. Biochem Med (Zagreb). 2019. PMID: 31223254 Free PMC article. Review.
-
Principles of and strategies for germline gene therapy.Nat Med. 2019 Jun;25(6):890-897. doi: 10.1038/s41591-019-0473-8. Epub 2019 Jun 3. Nat Med. 2019. PMID: 31160821 Review.
-
Comparative ethical evaluation of epigenome editing and genome editing in medicine: first steps and future directions.J Med Ethics. 2024 May 22;50(6):398-406. doi: 10.1136/jme-2022-108888. J Med Ethics. 2024. PMID: 37527926 Free PMC article.
-
Ethical Challenges of Germline Genetic Enhancement.Front Genet. 2019 Sep 3;10:767. doi: 10.3389/fgene.2019.00767. eCollection 2019. Front Genet. 2019. PMID: 31552088 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials